Press Release

Press Release | Dec 10, 2018

NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it has completed the acquisition of the parent company of Genoptix, Inc. for $125 million in cash, as adjusted by working capital and other adjustments, and 1 million shares of NeoGenomics common stock. Genoptix is a leading clinical oncology laboratory,

Press Release | Nov 27, 2018

Encore Dermatology, Inc. today announced the publication of a Phase 2, open-label study in SKIN The Journal of Cutaneous Medicine. Subjects treated with Impoyz (clobetasol propionate) Cream, 0.025% showed significantly lower mean post-treatment clobetasol propionate plasma concentrations versus the subjects treated with Temovate® (clobetasol propionate) Cream, 0.05% (56.3 vs 152.5 pg/mL, P=0.014).

Press Release | Nov 26, 2018

Innovative Health, a national leader in medical device reprocessing for the cardiology sector, announced it has received FDA clearances to reprocess the Advisor FL Circular Mapping Catheter, Medtronic’s Torqr™ and Marinr™, and Biosense Webster’s DECANAV. Three of these clearances were received within the last month alone.

Press Release | Oct 23, 2018

NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it has entered into a definitive agreement to acquire Genoptix, Inc. for $125 million in cash and 1 million shares of NeoGenomics common stock. Genoptix is a leading clinical oncology laboratory, specializing in hematology and solid tumor testing, with an

Press Release | Sep 10, 2018

Solsys Medical, LLC (“Solsys”) (formerly known and doing business as Soluble Systems, LLC) (“Solsys Medical”), which markets TheraSkin®, a cellular and tissue-based product for regenerative wound healing, announced today that it has partnered with Healogics, the nations largest provider of advanced chronic wound care services, to be a part of the new Healogics iSupply program,

Press Release | Sep 04, 2018

Genoptix, Inc., a leading oncology diagnostic laboratory, announces the immediate availability of a proprietary, FDA-authorized BCR-ABL MRDx® TFR Monitoring Test for patients with chronic myeloid leukemia (CML) being treated with Tasigna®(nilotinib). The test is commercially available in the U.S. exclusively through Genoptix. The BCR-ABL MRDx® TFR Monitoring Test is the only diagnostic test authorized by

Press Release | Aug 29, 2018

Colorescience®, a prominent dermatologist-recommended skin health cosmetics company, has earned its second award from O, The Oprah Magazine Fall Beauty O-Ward, for the new Sunforgettable® Total Protection™ Face Shield SPF 50. Launched in April of 2018, Face Shield is the first liquid SPF product for the face in the company’s portfolio that features their patented

Press Release | Aug 20, 2018

After a successful cross-country collaboration with the HydraFacial Nation World Tour, Colorescience®, the leading dermatologist-recommended skincare and cosmetics company, is excited to announce the next partnership between the two companies beginning in August 2018 that fully integrates Colorescience®’s into the PERK experience.

Pages 1 2 3 4 5